A. Hoffmeyer

Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma

M. Löhr, Brian Salmons, M. Freund, 2001, The Lancet.

Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study

H. Bergmeister, M. Löhr, U. Losert, 1999, Journal of Molecular Medicine.

Safety, feasibility and clinical benefit of localized chemotherapy using microencapsulated cells for inoperable pancreatic carcinoma in a phase I/II trial

M. Löhr, T. Wagner, H. Nizze, 2003 .

Intra-Arterial Instillation of Microencapsulated, Ifosfamide-Activating Cells in the Pig Pancreas for Chemotherapeutic Targeting

H. Bergmeister, M. Löhr, U. Losert, 2003, Pancreatology.

Intraarterial Instillation of Microencapsulated Cells in the Pancreatic Arteries in Pig

H. Bergmeister, M. Löhr, U. Losert, 1999, Annals of the New York Academy of Sciences.